Nearly two-thirds of U.S. ovarian cancer patients don't receive recommended treatment that could extend their lives, U.S. researchers have found (http://www.nytimes.com/2013/03/12/health/ovarian-cancer-study-finds-widespread-flaws-in-treatment.html?ref=health&_r=0).

For patients who didn't get…Read More

Nearly two-thirds of U.S. ovarian cancer patients don't receive recommended treatment that could extend their lives, U.S. researchers have found (http://www.nytimes.com/2013/03/12/health/ovarian-cancer-study-finds-widespread-flaws-in-treatment.html?ref=health&_r=0).

For patients who didn't get…Read More

Paul Cacciatore
Paul Cacciatore Campaign leader

The UK's National Institute for Health and Clinical Excellence (NICE) published draft guidance (http://www.nice.org.uk/newsroom/pressreleases/NICEDraftGuidanceDoesNotRecommendBevacizumabForRecurrentAdvancedOvarianCancer.jsp) today that fails to support the use of bevacizumab (Avastin) for treating…Read More

The lives of women with ovarian cancer in the UK are still being cut short because of delays to their diagnoses. The stark findings on delays are published as part of Target Ovarian Cancer's Pathfinder Study…Read More

Best friends Norma Leisle and Kathleen Walker are fighting ovarian cancer the way that's most natural to them: together. The two, who have both successfully battled breast cancer and are at different stages of their fights with ovarian cancer, rely heavily on their bond and a healthy sense of…Read More

See more